|
TEAD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.052800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.786400E-01 |
| Normal-vs-Stage2 |
3.416000E-01 |
| Normal-vs-Stage3 |
6.335800E-01 |
| Normal-vs-Stage4 |
7.085600E-01 |
| Stage1-vs-Stage2 |
1.256240E-01 |
| Stage1-vs-Stage3 |
8.755800E-01 |
| Stage1-vs-Stage4 |
8.847400E-01 |
| Stage2-vs-Stage3 |
1.800570E-01 |
| Stage2-vs-Stage4 |
2.465600E-01 |
| Stage3-vs-Stage4 |
9.798400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.424800E-01 |
| Normal-vs-AfricanAmerican |
7.346300E-02 |
| Normal-vs-Asian |
6.529200E-01 |
| Caucasian-vs-AfricanAmerican |
1.233560E-01 |
| Caucasian-vs-Asian |
2.449400E-01 |
| AfricanAmerican-vs-Asian |
2.784000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.828800E-01 |
| Normal-vs-Female |
4.548000E-01 |
| Male-vs-Female |
3.042400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.483400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.492000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.223400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.044200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.861600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.886400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.089600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.112440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.778800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.251600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.734600E-01 |
| Classical-VS-Follicular |
4.02788913334007E-13 |
| Classical-VS-Other |
7.677900E-02 |
| Classical-VS-Normal |
3.380400E-02 |
| Tall-VS-Follicular |
1.23230000004249E-06 |
| Tall-VS-Other |
4.651600E-02 |
| Tall-VS-Normal |
8.810000E-02 |
| Follicular-VS-Other |
6.022200E-01 |
| Follicular-VS-Normal |
1.985060E-04 |
| Other-VS-Normal |
2.048800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.335800E-01 |
| Normal-vs-N1 |
8.846600E-01 |
| N0-vs-N1 |
4.218800E-01 |
|
|
